What is the step‑by‑step technique for performing an inguinal radical orchiectomy in an adult male with a suspected testicular neoplasm?

Inguinal Radical Orchiectomy: Step-by-Step Technique

Inguinal radical orchiectomy with division of the spermatic cord at the internal inguinal ring is the gold standard initial intervention for suspected testicular cancer, and a scrotal approach must be avoided due to higher local recurrence rates. 1

Pre-Operative Considerations

Serum Tumor Markers

• Draw serum α-fetoprotein (AFP), β-hCG, and lactate dehydrogenase (LDH) before surgery to support diagnosis and establish baseline for post-operative monitoring 1
• Consider obtaining cord blood sample at time of surgery for tumor marker analysis 2

Fertility Preservation

• Offer semen cryopreservation ideally before orchiectomy, as sperm abnormalities and Leydig cell dysfunction are frequently present even before surgery 1
• This maximizes chances of future fertilization 1

Testicular Prosthesis Discussion

• Discuss prosthesis insertion at time of orchiectomy with the patient, as it decreases psychological effects of castration and does not delay adjuvant treatment 2

Imaging Confirmation

• High-frequency (>10 MHz) testicular ultrasound should confirm intratesticular mass location, size, multifocal disease, and contralateral testis characteristics 1

Surgical Technique

Incision and Approach

• Make an inguinal incision overlying the external inguinal ring, extending through skin and subcutaneous tissue 3
• Incise the external oblique aponeurosis to expose the inguinal canal 3
• The standard approach requires opening the inguinal canal and dividing the spermatic cord at the internal inguinal ring 1, 3

Cord Control and Mobilization

• Identify and isolate the spermatic cord at the level of the pubic tubercle before manipulating the testis 3
• Apply early vascular control by clamping the cord at the internal ring level to prevent tumor dissemination during manipulation 3
• Mobilize the cord and testis en bloc from the scrotum through the inguinal incision 3

Cord Division

• Divide the spermatic cord at the internal inguinal ring with high ligation 1, 3
• This ensures removal of the entire cord length and minimizes risk of residual disease 3
• Ligate the cord vessels securely to prevent hematoma formation 3

Specimen Removal

• Deliver the testis with attached cord and tunica vaginalis intact through the inguinal incision 3
• Avoid violating the tunica albuginea during removal 3

Hemostasis and Closure

• Achieve meticulous hemostasis in the inguinal canal and scrotal compartment 3
• Close the external oblique aponeurosis 3
• Close subcutaneous tissue and skin in layers 3

Alternative Technique: Subinguinal Approach

When to Consider

• The subinguinal approach divides the cord at the external inguinal ring, avoiding opening the inguinal canal 4, 5
• This technique may reduce risk of neuropathic injury to ilioinguinal nerve and incisional hernia 4

Oncological Considerations

• Current evidence shows no significant differences in oncological outcomes between subinguinal and high inguinal approaches for stage 1 and stage 2-4 cancers 5
• However, 12.5% of subinguinal cases showed unsatisfactory oncological control, with 78% due to cancer relapse and 16.5% due to spermatic cord invasion 5
• Given these concerns about residual proximal cord disease, the traditional high inguinal approach with cord division at the internal ring remains the standard of care 1, 3

Critical Technical Points

Avoid Scrotal Violation

• Never use a scrotal approach, as this is associated with higher local recurrence rates 1
• The inguinal approach provides proper oncological control 1

Early Vascular Control

• Clamp the cord early before extensive testicular manipulation to prevent hematogenous tumor spread 3

Complete Cord Excision

• Ensure division at the internal inguinal ring to remove all potentially involved cord tissue 1, 3
• Incomplete cord excision may leave residual disease 5

Special Circumstances

Testis-Sparing Surgery

• Only offer to well-informed patients with: single testicle, excellent compliance, single tumor <2 cm at lower pole, and normal preoperative endocrine function 1
• Take at least two additional biopsies from remaining testis to exclude germ cell neoplasia in situ (GCNIS) 1
• May also be considered for small/indeterminate masses with negative markers and normal contralateral testis 1

Contralateral Biopsy

• Offer to patients at high risk for contralateral GCNIS: testicular volume <12 ml and/or history of cryptorchidism 1
• Not indicated in patients >40 years without risk factors 1

Post-Operative Management

Tumor Marker Follow-Up

• Repeat serum tumor markers post-operatively considering half-life kinetics (AFP: 5-7 days, β-hCG: 24-36 hours) 1
• Delayed decline or rising levels provide staging and prognostic information 1

Histopathological Assessment

• Pathology report must include: tumor type, pT stage, vascular/lymphatic invasion, involvement of tunica albuginea/vaginalis, spermatic cord invasion, and surgical margin status 6
• These elements determine need for adjuvant therapy and surveillance strategy 6